Update on the Development of Anti-Viral Agents Against Hepatitis C

Hepatitis C virus (HCV) infects nearly 170 million people worldwide and causes chronic hepatitis, cirrhosis, and hepatocellular carcinoma. The search for a drug regimen that maximizes efficacy and minimizes side effects is quickly evolving. This review will discuss a wide range of drug targets curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Macarthur, Kristin L., Smolic, Robert, Smolic, Martina V., Wu, Catherine H., Wu, George Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Ltd 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521270/
https://www.ncbi.nlm.nih.gov/pubmed/26357602
http://dx.doi.org/10.14218/JCTH.2013.007XX

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521270/
https://www.ncbi.nlm.nih.gov/pubmed/26357602
http://dx.doi.org/10.14218/JCTH.2013.007XX

Ejemplares similares